Chittorgarh.com Logo
Loading...

Dr Lalchandani Labs Limited IPO Message Board (Page 1)

Loading...
Small Investor
49. Small Investor  May 24, 2018 14:41
IPO Guru IPO Guru (1400+ Posts, 800+ Likes)
whhhha today Up 7.5%
PAPU
48. PAPU  May 23, 2018 12:32
DON'T SELL IT IT WILL BE MULTIBAGAR LIKE Dr. Lal PathLabs Ltd IN NEXT 10 YEAR SO DON'T SOLD IT IF YOU HAVE EXTRA MONEY IF YOU DON'T HAVE SOLD IT
VIJMISHRA
47. VIJMISHRA  May 12, 2018 00:27
Any suggestion on Dr. LAL LAB SHALL I HOLD IT AND AVERAGE IT OR SELL and BOOK LOSS
IPOANALYSIS
47.1. IPOANALYSIS  May 14, 2018 11:01
IPO Guru IPO Guru (1900+ Posts, 1500+ Likes)
sell .
fair value is 12 rs
SecTheta
46. SecTheta  May 10, 2018 17:16
Manipulated Financials. CLEAR AVOID!
Carn Mohan
45. Carn Mohan  May 9, 2018 19:34
IPO Mentor IPO Mentor (700+ Posts, 200+ Likes)
Never invest any ipo where lead manager will Navigant Corporate Advisors Ltd Lead Manager last 3 IPOs are trading in huge discount totly failed leadmanager.
IPOANALYSIS
45.1. IPOANALYSIS  May 9, 2018 22:25
IPO Guru IPO Guru (1900+ Posts, 1500+ Likes)
Carn Mohan I already told u before.however u can use the money to invest in dhruv to get profits and cover ur losses from this one. Next in line from navigant is sirca paints. I hope people learn lesson and not subscribe sirca at all
Carn Mohan
44. Carn Mohan  May 9, 2018 16:20
IPO Mentor IPO Mentor (700+ Posts, 200+ Likes)
Navigant Corporate Advisors Ltd is not a good lead manager Loot liya
Small Investor
43. Small Investor  May 9, 2018 11:13
IPO Guru IPO Guru (1400+ Posts, 800+ Likes)
Lal Lal Chand pr Nya Nya Loss dekhkr bhayo ka mood bigd gya
Carn Mohan
42. Carn Mohan  May 9, 2018 10:47
IPO Mentor IPO Mentor (700+ Posts, 200+ Likes)
Sold all shares ,Lead manager very poor.
vikasdds
41. vikasdds  May 9, 2018 10:22
chore hai sala
IPOANALYSIS
40. IPOANALYSIS  May 9, 2018 09:52
IPO Guru IPO Guru (1900+ Posts, 1500+ Likes)
Listed below issue price at 29.95. as predicted. Congratulation to navigant for 3 continuous listing Badly. Continental seeds then power instrumentation and this one. Next in line Is sirca paints
RAJAKUMAR
40.1. RAJAKUMAR  May 9, 2018 10:15
IPO Guru IPO Guru (1400+ Posts, 1100+ Likes)
Dhruv is Hem
IPOANALYSIS
40.2. IPOANALYSIS  May 9, 2018 10:20
IPO Guru IPO Guru (1900+ Posts, 1500+ Likes)
Laskya is funny. He doesn't know company fundamentals and hasn't studied or gone through prospectus of dhruv and is either eager to buy at good price. Dhruv will be a multibagger in long run. Lol. Keep dreaming as no-one is interested in your comments
RAJAKUMAR
39. RAJAKUMAR  May 9, 2018 10:03
IPO Guru IPO Guru (1400+ Posts, 1100+ Likes)
Lower circuit 28.5
SecTheta
38. SecTheta  May 9, 2018 08:42
Listing should be around 31
Let's see. Good luck!!
Sinewave
37. Sinewave  May 9, 2018 08:01
IPO Mentor IPO Mentor (500+ Posts, 300+ Likes)
Listing today.

Best wishes to allottees.
Carn Mohan
36. Carn Mohan  May 9, 2018 07:14
IPO Mentor IPO Mentor (700+ Posts, 200+ Likes)
Very good company easily cross Rs 60/
IPOANALYSIS
35. IPOANALYSIS  May 8, 2018 11:12
IPO Guru IPO Guru (1900+ Posts, 1500+ Likes)
Its a sell on listing day stock.
Navigant has reputation and very bad movement of all its scrip and mostly on downside
Carn Mohan
34. Carn Mohan  May 7, 2018 17:44
IPO Mentor IPO Mentor (700+ Posts, 200+ Likes)
Anybody received allotted shares in D.mat account
VIJMISHRA
34.1. VIJMISHRA  May 8, 2018 09:55
Got msg but yet not credited in D-mat account
Carn Mohan
33. Carn Mohan  May 8, 2018 06:40
IPO Mentor IPO Mentor (700+ Posts, 200+ Likes)
10
NIKKI
32. NIKKI  May 7, 2018 21:16
What is the listing date?
VIJMISHRA
31. VIJMISHRA  May 6, 2018 11:36
2 Applied and 1 allotted
Carn Mohan
30. Carn Mohan  May 6, 2018 07:19
IPO Mentor IPO Mentor (700+ Posts, 200+ Likes)
If we annualize latest earnings and attribute it on fully diluted equity post issue, then asking price is at a P/E of around 10 thus issue appears reasonably priced. As per offer document it has no listed peers. Although on the basis of scale, they are not comparable in true sense, we may consider main board peers like Thyrocare, Dr. Lal Path that are trading at a P/E of around 38 and 43 (as on 18.04.18 closing).